High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of recurrent glioblastoma

Glioblastoma Multiforme (GBM) is the most common primary brain tumour in adults, yet survival outcomes remain poor. First line treatment is well established but with disease recurrence almost inevitable, improving prognosis is challenging. With the aim of personalising therapy at recurrence we have...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Taylor, Jessica, Yu, Kenny, Pathmanaban, Omar, Beyit, Deniz, Dutko-Gwozdz, Joanna, Benson, Rod, Griffiths, Gareth, McBain, Catherine, Peers, Ian, Ceuppens, Peter, Kamaly-asl, Ian, Bigger, Brian
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791612/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox237.024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars